Apramycin Acetate-d7 (Major)

Apramycin Acetate-d7 (Major) is a deuterated form of Apramycin Acetate, which is an aminoglycoside antibiotic. It is mainly used in the treatment of bacterial infections caused by Gram-negative organisms, including Escherichia coli, Salmonella, and Klebsiella. Apramycin Acetate-d7 (Major) is used for research purposes only and is not approved for human use. Chemically, Apramycin Acetate-d7 (Major) is a deuterated form of the parent compound, Apramycin Acetate. Deuterium is a stable isotope of hydrogen with a neutron in its nucleus, which makes it heavier than the normal hydrogen atom. The incorporation of deuterium into the molecule of Apramycin Acetate-d7 (Major) makes it useful in various research applications, such as metabolic studies, pharmacokinetics, and drug-drug interactions. The mechanism of action of Apramycin Acetate-d7 (Major) is similar to that of other aminoglycoside antibiotics. It binds to the bacterial ribosome and inhibits protein synthesis, leading to bacterial cell death. Apramycin Acetate-d7 (Major) is effective against bacteria that are resistant to other antibiotics, making it a valuable tool in antibiotic research. In conclusion, Apramycin Acetate-d7 (Major) is a deuterated form of Apramycin Acetate that is used for research purposes only. It is effective against Gram-negative bacterial infections and is useful in various research applications. Its incorporation of deuterium makes it a useful tool in the study of pharmacokinetics and drug-drug interactions.